/DEAR.ST

DEAR.ST Stock - Duearity AB (publ)

Q: What is the analyst price target for DEAR.ST?

Analyst price target information is not currently available for DEAR.ST.

Q: What is DEAR.ST's market cap?

Market capitalization information is not currently available for DEAR.ST.

Healthcare|Medical - Devices|STO

$0.02+0.00%

+$0.00 (+0.00%) • Sep 6

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.02

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for DEAR.ST

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2020

FY2021

FY2022

FY2023

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta1.80

52W High$2.29

52W Low$0.01

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2023	FY2022	FY2021	FY2020
Revenue	$1.65M	N/A	$174,481	$624
Gross Profit	$-4,178,000	$-6,376,000	$-15,345,379	$-957,376
Gross Margin	-252.6%	N/A	-8794.9%	-153425.6%
Operating Income	$-25,763,000	$-19,166,000	$-15,359,511	$-1,325,000
Net Income	$-26,190,000	$-19,314,000	$-15,518,597	$-1,325,000
Net Margin	-1583.4%	N/A	-8894.1%	-212339.7%
EPS	$-0.40	$-1.27	$-1.30	$-0.09

Company Overview

Duearity AB (publ), a medical technology company, engages in the development of Tinearity, a tinnitus aid. The company's Tinearity contains a small sound element that generates white noise directly into the ear via the skull. It also develops Tinearity AI, an artificial intelligence-based solution that would help people suffering from or bothered by tinnitus to take command and master their symptoms. The company was incorporated in 2020 and is based in Malmö, Sweden.

Visit Website

Earnings History & Surprises

DEAR.ST

Beat Rate

Last 0 quarters

Avg Surprise

+0%

EPS vs Estimate

Beats / Misses

0/0

Last 12 quarters

Latest EPS

$-0.48

Q3 2023

EPS Surprise History

Q4 22

No data

Q1 23

No data

Q2 23

No data

Q3 23

No data

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q4 2023	Dec 31, 2023	—	—	—	—
Q3 2023	Sep 30, 2023	—	$-0.48	—	—
Q2 2023	Jun 30, 2023	—	$-0.37	—	—
Q1 2023	Mar 31, 2023	—	$-0.21	—	—
Q4 2022	Dec 31, 2022	—	$-0.29	—	—